/>

Friday, December 21, 2018

NEWS 21 DEC 2018

NEWS FROM USA

New Paragraph IV filing

DRUG

Dosage form

Corresponding RLD

Date of Submission

Type of Submission (Based on Date)

Carfilzomib

(10 mg/vial)

Injection

Kyprolis

28 Nov 2018

Post NCE-1 submission for new strength

Nintedanib

Softgel Capsules

Ofev

15 Oct 2018

NCE-1

 

NDA Approvals                    

Approval Date

Drug

NDA Sponsor

Brand Name

Prescribing information

19 Dec 2018

Diclofenac Epolamine Shampoo

(505(b)2 approval)

Institut Biochimique

Licart

Link

21 Dec 2018

Levetiracetam extended release

(505(b)2 approval)

Sun Pharma

Elepsia XR

Link

 

505 (b) 2s in pipeline

Asenapine transdermal patch (Hisamitsu): Hisamitsu submits New Drug Application of Asenapine transdermal patch in the US.

 

Minocycline foam 4% (Foamix): Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne.

 

ANDA Approvals              

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

19 Dec 2018

Benzonatate Capsule

Puracap Pharma

Tessalon (Pfizer)

Ten

19 Dec 2018

Pramipexole Dihydrochloride Tablets

Unichem 

Mirapex (Boehringer)

Fourteen

19 Dec 2018

Metoprolol Succinate ER Tablets

Twi Pharms

Toprol-Xl(Aralez)

Seven

19 Dec 2018

Potassium Chloride ER Tablets

Aurobindo 

Klor-Con (Upsher)

Six

 

Tentative ANDA Approvals 

Approval Date

Drug

Company

19 Dec 2018

Alogliptin; Metformin Hydrochloride

Torrent 

 

 

 

Other News from the USA

FDA publishes updated list of Off-Patent, Off-Exclusivity Drugs without an Approved Generic (Link)

If you have any query/suggestion then please write us at pharmacaption@gmail.com

                                                                                                                     

 

 

 

 

                                                                

No comments:

Post a Comment